These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 365763)

  • 1. Strain difference of delayed-type hypersensitivity to BCG and its genetic control in mice.
    Nakamura RM; Tokunaga T
    Infect Immun; 1978 Dec; 22(3):657-64. PubMed ID: 365763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mouse-strain difference in immunoprophylactic and immunotherapeutic effects of BCG on carcinogen-induced autochthonous tumors.
    Tokunaga T; Yamamoto S; Nakamura RM; Kurosawa A; Murohashi T
    Jpn J Med Sci Biol; 1978 Apr; 31(2):143-54. PubMed ID: 682371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of immune responses of mice immunized with five different Mycobacterium bovis BCG vaccine strains.
    Lagranderie MR; Balazuc AM; Deriaud E; Leclerc CD; Gheorghiu M
    Infect Immun; 1996 Jan; 64(1):1-9. PubMed ID: 8557324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Difference in antigen-presenting ability of macrophages between high- and low-responder mice in delayed-type hypersensitivity to Mycobacterium bovis BCG.
    Nakamura RM; Tokunaga T; Yamamoto S
    Infect Immun; 1980 Jan; 27(1):268-70. PubMed ID: 6965664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strain difference in delayed-type hypersensitivity to BCG in mice: role of splenic adherent cells in the primary immune response.
    Nakamura RM; Tanaka H; Tokunaga T
    Immunology; 1982 Dec; 47(4):729-31. PubMed ID: 6216204
    [No Abstract]   [Full Text] [Related]  

  • 6. Non-specific suppression of delayed-type hypersensitivity by intrathymic injection of killed bacteria.
    Kato K; Yamamoto K
    Thymus; 1984; 6(1-2):79-87. PubMed ID: 6205480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of suppressor T cells in delayed-type hypersensitivity to Mycobacterium bovis BCG in low-responder mice.
    Nakamura RM; Tokunaga T
    Infect Immun; 1980 May; 28(2):331-5. PubMed ID: 6447109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic control of granuloma response to oil-associated BCG cell wall vaccine in mice.
    Yamamoto K; Karinuma M
    Microbiol Immunol; 1978; 22(6):335-48. PubMed ID: 357935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ribosomal protein L7 included in tuberculin purified protein derivative (PPD) is a major heat-resistant protein inducing strong delayed-type hypersensitivity.
    Kitaura H; Kinomoto M; Yamada T
    Scand J Immunol; 1999 Dec; 50(6):580-7. PubMed ID: 10607306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of cytotoxic T-cell responses against culture filtrate antigens in Mycobacterium bovis bacillus Calmette-Guérin-infected mice.
    Denis O; Lozes E; Huygen K
    Infect Immun; 1997 Feb; 65(2):676-84. PubMed ID: 9009330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of delayed-type hypersensitivity during Mycobacterium lepraemurium infection in mice.
    Poulter LW; Lefford MJ
    Infect Immun; 1977 Aug; 17(2):439-46. PubMed ID: 330412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strain differences in lung granuloma formation in response to a BCG cell-wall vaccine in mice. Failure of antigen presentation by low-responder macrophages.
    Kakinuma M; Onoé K; Yasumizu R; Yamamoto K
    Immunology; 1983 Nov; 50(3):423-31. PubMed ID: 6354921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of BCG vaccination on murine leprosy in C57BL/6 and C3H mice.
    Lagrange PH; Hurtrel B
    Ann Immunol (Paris); 1979; 130C(5):687-709. PubMed ID: 393159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of bcg strains for delayed hypersensitivity induction tested in vivo in guinea pigs and in vitro.
    Smerák P; Průchová J; Sír Z
    J Hyg Epidemiol Microbiol Immunol; 1982; 26(4):435-44. PubMed ID: 6761395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of BCG cell wall induced delayed-type hypersensitivity by BCG pre-treatment. I. Induction of adherent suppressor cells by live BCG injection and their characterization.
    Kato K; Yamamoto KI; Kakinuma M; Ishihara C; Azuma I
    Immunology; 1981 Feb; 42(2):259-66. PubMed ID: 6450731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and characterization of a BCG antigen expressed at the membrane surface of in vitro infected mouse peritoneal macrophages.
    Denis M; Forget A; Skamene E
    Clin Exp Immunol; 1989 Oct; 78(1):127-32. PubMed ID: 2478326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms in the in vivo release of lymphokines: relationship of high and low responsiveness to other parameters of the immune response.
    Neta R; Salvin SB
    Infect Immun; 1981 Oct; 34(1):160-5. PubMed ID: 6170585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigen provoking gamma interferon production in response to Mycobacterium bovis BCG and functional difference in T-cell responses to this antigen between viable and killed BCG-immunized mice.
    Kawamura I; Yang J; Takaesu Y; Fujita M; Nomoto K; Mitsuyama M
    Infect Immun; 1994 Oct; 62(10):4396-403. PubMed ID: 7927701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of systemic BCG infection in syrian golden hamsters.
    Zwilling BS; Davis GW
    Infect Immun; 1976 Jul; 14(1):271-6. PubMed ID: 780276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of antimycobacterial Th1-cell responses by a Mycobacterium bovis BCG prime-protein boost vaccination strategy.
    Lu M; Xia ZY; Bao L
    Cell Immunol; 2013; 285(1-2):111-7. PubMed ID: 24177251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.